ArticleInternational journal of clinical oncology2023

Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.

Mizuki Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.